Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Willis Towers Watson (WTW)

WTW Q1 revenue falls 5% to $2.2 billion on TRANZACT sale; organic growth is 5%

Mixed Impact 3 of 5 earnings Written later

WTW reported first-quarter 2025 results for the period ended March 31, 2025. Reported revenue fell 5% to $2.2 billion, mainly because of the sale of TRANZACT, while organic revenue grew 5%. Diluted EPS rose 27% to $2.33, but adjusted diluted EPS was flat at $3.13, and free cash flow was negative $86 million.

Key points

  • Revenue was $2,223 million, down 5% from $2,341 million a year earlier; organic revenue rose 5%.
  • Diluted EPS was $2.33, up 27%; adjusted diluted EPS was $3.13, flat year over year.
  • Free cash flow was $(86) million versus $(36) million in the prior-year quarter, mainly due to the absence of TRANZACT cash collections.
  • WTW repurchased 607,221 shares for $200 million in the quarter and expects share repurchases of about $1.5 billion in 2025.

The filing

CompanyWillis Towers Watson (WTW)
Form8-K, current report
Filed with the SECApr 24, 2025, 6:00 AM ET
Accession number0001171843-25-002453

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 24, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.